This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Acute myeloid leukaemia, helper endpoint
HLP_C3_AML
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
383 |
4. Check minimum number of eventsNone |
383 |
5. Include endpointsNone |
383 |
6. Filter based on genotype QC (FinnGen only) |
353 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Acute myeloid leukaemia, helper endpoint
based on the number of shared cases.
Similar with more cases:
- Acute myeloid leukaemia
- Acute myeloid leukaemia, including Hilmo
- Acute myeloid leukaemia and myelodysplastic syndromes
- Liquid cancers, helper endpoint
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 353 | 146 | 207 |
| Unadjusted period prevalence (%) | 0.08 | 0.05 | 0.09 |
| Median age at first event (years) | 67.43 | 61.82 | 71.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 383
- Matched controls
- 3830
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
319.2
260
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
320.2
307.7
266
27
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
307.7
336
*
XW000
NOMESCO Finland
Bone marrow biopsy
103.6
307.7
207
43
WW500
NOMESCO Finland
Blood transfusion
77.2
260.7
145
30
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
61.2
196.5
113
26
A04AA01
ATC
ondansetron; systemic, rectal
52.3
187.7
112
30
127
Kela drug reimbursment
Transplant complication
77.5
138.2
75
12
A05AA02
ATC
ursodeoxycholic acid; oral
50.2
118.4
70
17
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
14.0
87.3
89
81
L03AA02
ATC
filgrastim; parenteral
988.8
83.8
79
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
50.9
76.9
45
10
Z51.5
ICD-10 Finland
Palliative care
14.5
75.0
73
61
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.7
71.6
126
229
H02AB02
ATC
dexamethasone; systemic
34.5
66.4
43
14
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
63.3
59
*
J05AB11
ATC
valaciclovir; oral
6.6
63.0
130
275
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
17.5
60.8
52
34
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
678.2
60.5
58
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
349.1
60.1
59
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
23.0
60.1
45
22
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.7
57.6
112
222
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.6
55.4
66
74
R50.9
ICD-10 Finland
Fever, unspecified
5.9
55.4
130
307
L04AD01
ATC
ciclosporin; systemic
24.7
52.4
38
17
J01MA12
ATC
levofloxacin; systemic
5.2
51.4
147
409
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.9
50.5
69
92
ZX120
NOMESCO Finland
Intravenous
7.8
50.3
79
124
JN4BD
NOMESCO Finland
Extensive body CT
9.5
50.2
65
81
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
50.1
47
*
A41.9
ICD-10 Finland
Sepsis, unspecified
9.7
48.6
61
73
JN4AD
NOMESCO Finland
Body CT examination
8.8
44.6
61
81
J02AC03
ATC
voriconazole; systemic
228.8
40.7
41
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
40.3
38
*
WW200
NOMESCO Finland
Immunization
13.5
39.9
39
32
M04AA01
ATC
allopurinol; systemic
4.6
39.9
125
366
D64.9
ICD-10 Finland
Anaemia, unspecified
5.0
39.4
104
265
TGC00
NOMESCO Finland
Bronchial lavation
13.1
38.2
38
32
D70.89
ICD-10 Finland
Neutropenic splenomegaly
91.7
37.6
41
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.1
37.3
37
31
N02AA05
ATC
oxycodone; systemic
4.4
35.1
110
319
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
351.6
32.4
32
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
124.0
32.2
34
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
7.8
30.8
45
64
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
30.6
29
*
A04AA02
ATC
granisetron; systemic, transdermal
326.9
30.2
30
*
J01MA14
ATC
moxifloxacin; systemic
5.0
30.2
74
175
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
29.6
28
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
29.6
28
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
29.0
92
266
L01BB02
ATC
mercaptopurine; oral
46.5
28.2
34
8
L03AA13
ATC
pegfilgrastim; parenteral
302.5
28.1
28
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
302.5
28.1
28
*
ZX112
NOMESCO Finland
Subcutaneous
34.8
27.4
35
11
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
26.4
25
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
26.4
25
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.7
25.9
38
54
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
25.5
111
397
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
25.3
24
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
25.3
24
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
25.3
24
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
25.5
25.3
35
15
B73
ICPC
Leukaemia
+∞
24.2
23
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
23.7
216
1171
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
23.2
22
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.6
23.0
39
65
115
Kela drug reimbursment
Breast cancer
+∞
22.1
21
*
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
22.1
21
*
J02AC04
ATC
posaconazole; systemic
+∞
22.1
21
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
232.7
21.8
22
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
36.2
21.4
27
8
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
39.7
21.0
26
7
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
21.0
20
*
J05AB01
ATC
aciclovir; systemic
3.1
20.3
110
443
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.8
20.2
29
40
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
20.0
19
*
WW409
NOMESCO Finland
Other aferesis
+∞
20.0
19
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
77.4
19.9
22
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
19.1
47
110
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
18.9
18
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
70.1
17.9
20
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
70.1
17.9
20
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
17.8
17
*
116
Kela drug reimbursment
Prostate cancer
+∞
17.8
17
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.2
17.6
27
40
WZC00
NOMESCO Finland
Treatment plan or consultation
2.7
17.1
122
563
J02AC01
ATC
fluconazole; systemic
2.6
17.1
152
782
L04AA06
ATC
mycophenolic acid; systemic
15.2
16.6
27
19
212
Kela drug reimbursment
Gout
6.5
16.2
27
44
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
15.9
154
818
ZX090
NOMESCO Finland
Other technic of radiotherapy
62.8
15.9
18
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
62.8
15.9
18
*
L02AE02
ATC
leuprorelin; implant, parenteral
62.8
15.9
18
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
15.7
15
*
ZX121
NOMESCO Finland
Central venous catheter
166.5
15.6
16
*
TAB00
NOMESCO Finland
Lumbar puncture
5.4
15.5
32
64
L01XX05
ATC
hydroxycarbamide; oral
12.0
15.5
28
25
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
30.0
15.3
20
7
L04AA01
ATC
[U] ciclosporin
24.6
15.3
21
9
GD1AD
NOMESCO Finland
Thorax CT examination
4.8
15.0
35
78
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
26.3
14.8
20
8
H02AB09
ATC
hydrocortisone; systemic
11.5
14.7
27
25
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
14.7
14
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
14.5
44
121
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
14.0
45
129
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
13.8
122
615
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.1
13.8
30
63
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
13.6
13
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
13.6
13
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
13.6
13
*
1DB06, ,
NOMESCO Finland
+∞
13.6
13
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
26.9
13.5
18
7
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.9
13.3
41
114
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
51.9
12.9
15
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
14.7
12.9
21
15
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
12.6
12
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
12.6
12
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
12.6
12
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
12.5
142
792
C90.0
ICD-10 Finland
Multiple myeloma
134.2
12.5
13
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
134.2
12.5
13
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.1
12.1
26
54
WF002
NOMESCO Finland
Radical radiotherapy
48.3
12.0
14
*
A41.8
ICD-10 Finland
Other specified sepsis
9.7
11.7
23
25
A40.8
ICD-10 Finland
Other streptococcal sepsis
14.2
11.6
19
14
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
11.5
11
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
11.5
11
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
123.6
11.5
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.8
10.8
20
36
L02BA01
ATC
tamoxifen; oral
113.0
10.5
11
*
2AX04, ,
NOMESCO Finland
+∞
10.5
10
*
Y77
ICPC
Malignant neoplasm prostate
+∞
10.5
10
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
10.5
10
*
ZXD05
NOMESCO Finland
Urgent procedure
2.1
10.3
126
715
L02BG04
ATC
letrozole; oral
24.1
10.3
14
6
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.0
10.2
48
174
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
15.1
10.1
16
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
9.9
91
459
L04AD02
ATC
tacrolimus; systemic
20.7
9.9
14
7
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
9.9
36
112
D64.8
ICD-10 Finland
Other specified anaemias
11.8
9.7
17
15
JN4CD
NOMESCO Finland
Very extensive body CT
9.5
9.6
19
21
J05AX18
ATC
letermovir; oral
+∞
9.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
9.4
9
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
9.4
9
*
1DB07, ,
NOMESCO Finland
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
JN6AD
NOMESCO Finland
CT of torso and neck
22.4
9.4
13
6
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.9
9.1
27
73
TPH00
NOMESCO Finland
Phlebotomy
19.2
9.0
13
7
HA1AA
NOMESCO Finland
X-ray mammography
7.1
9.0
21
31
306
Kela drug reimbursment
Erythropoietin and darbepoetin
51.2
8.7
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
92.0
8.4
9
*
PJA12
NOMESCO Finland
Sentinel node biopsy
92.0
8.4
9
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
130
Kela drug reimbursment
Malignant tumour
+∞
8.4
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
B02AA02
ATC
tranexamic acid; systemic
2.6
8.2
50
208
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.9
8.2
18
38
5BA08, ,
NOMESCO Finland
34.1
8.1
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
8.1
35
121
R4110
NOMESCO Finland
Physiotherapy
2.0
8.1
102
579
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
22.6
8.1
11
5
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
22.6
8.1
11
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
7.8
31
102
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
25.6
7.6
10
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
25.6
7.6
10
*
H02AB04
ATC
methylprednisolone; systemic
2.2
7.5
67
332
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
7.5
54
244
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
7.5
145
948
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
81.6
7.4
8
*
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.3
155
1039
A07AA02
ATC
nystatin; oral
3.2
7.3
29
95
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
7.3
50
220
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
+∞
7.3
7
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
1BC07, ,
NOMESCO Finland
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
7.3
7
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
7.3
7
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
7.3
22
60
D11AH01
ATC
tacrolimus; topical
16.1
7.3
11
7
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.2
7.2
15
19
B01AB05
ATC
enoxaparin; parenteral
1.9
7.0
111
677
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.5
7.0
17
27
A98
ICPC
Health maint/preventive medicine
0.5
7.0
253
2995
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.8
7.0
15
20
ZXE00
NOMESCO Finland
One hour or less
1.8
6.8
140
925
H02AB06
ATC
prednisolone; systemic
1.8
6.7
178
1267
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.7
6.7
21
59
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.8
6.6
20
55
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
6.5
27
91
ED1AA
NOMESCO Finland
Mandibular X-ray examination
71.0
6.4
7
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
71.0
6.4
7
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
71.0
6.4
7
*
Z3231
NOMESCO Finland
Registered nurse
1.9
6.4
105
645
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
18.4
6.3
9
5
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.3
6.3
16
504
J02AC05
ATC
isavuconazole; systemic
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
1518, ,
Kela drug reimbursment
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
399
Kela drug reimbursment
Venetoclax
+∞
6.3
6
*
L01XX52
ATC
venetoclax; oral
+∞
6.3
6
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
6.3
6
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.3
6.3
23
72
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.7
6.1
34
135
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
130
34
57.37
220.50
6.8
1.4
—
—
—
0
0
115
43
37.79
174.80
1.4
1.4
—
—
—
0
0
110
37
41.31
172.71
1.6
1.6
108.81
102.57
u/ml
—
32
7
99
34
38.92
153.84
13.3
5.5
575.05
977.80
iu/ml
—
20
5
102
42
32.74
149.18
1.5
1.4
235.25
172.50
u/ml
1.23
65
22
89
51
22.43
112.91
5.1
1.3
—
—
—
0
0
80
37
27.07
110.99
4.9
1.3
—
—
—
0
0
80
37
27.07
110.99
4.9
1.3
—
—
—
0
0
89
56
20.40
107.90
4.9
1.3
—
—
—
0
0
76
40
23.46
99.70
5.2
1.2
—
—
—
0
0
177
349
8.57
95.93
8.4
2.0
1.77
1.65
%
0.59
172
309
85
63
17.06
94.29
1.5
1.7
—
—
—
0
0
150
251
9.18
93.96
8.5
2.0
58.00
64.85
e9/l
0.92
125
206
52
12
49.98
88.40
1.8
1.1
—
—
—
0
0
70
0
+∞
75.57
1.0
0.0
—
—
—
0
0
53
23
26.58
74.54
2.5
1.3
—
—
—
0
0
53
23
26.58
74.54
2.5
1.3
—
—
—
0
0
51
22
26.59
71.83
6.1
1.3
—
—
—
0
0
161
381
6.57
70.18
14.2
3.0
0.81
0.83
mmol/l
1.19
154
350
51
24
24.36
69.41
6.1
1.3
—
—
—
0
0
91
125
9.24
65.72
1.6
1.6
1.65
1.55
g/l
0.34
79
108
55
36
17.67
64.39
2.0
1.4
—
—
—
0
0
47
23
23.15
62.81
1.2
1.0
—
—
—
0
0
47
25
21.29
60.59
2.9
1.2
—
—
—
0
0
105
188
7.32
59.75
4.0
1.5
—
—
—
0
0
49
31
17.98
58.21
2.6
1.2
—
—
—
0
0
43
22
21.89
56.27
4.9
1.9
—
—
—
0
0
45
27
18.75
54.78
1.8
1.2
—
—
—
0
0
38
20
20.98
48.98
1.7
1.5
—
—
—
0
0
39
23
18.77
47.72
7.1
1.2
—
—
—
0
0
39
23
18.77
47.72
7.1
1.2
—
—
—
0
0
39
23
18.77
47.72
7.1
1.2
—
—
—
0
0
190
734
4.15
41.78
11.1
2.5
307.67
8954.71
umol/l
4.12
184
627
56
79
8.13
38.79
2.6
1.2
—
—
—
0
0
142
475
4.16
37.61
5.2
1.7
—
—
—
0
0
38
33
12.67
37.49
2.1
1.3
—
—
—
0
0
36
29
13.60
37.16
2.2
1.4
—
—
—
0
0
56
87
7.37
35.55
3.2
3.3
—
—
—
0
0
157
590
3.81
34.75
3.4
1.7
4.07
1.15
mg/l
2.87
142
444
49
69
8.00
33.87
1.7
2.0
38.51
12.29
mg/l
1.26
40
63
39
9
48.07
32.51
6.0
1.0
380.82
875.56
e6/l
—
39
9
238
1226
3.49
31.16
26.0
5.4
33.44
26.96
%
8.71
231
1130
234
1197
3.45
30.90
25.3
5.3
1.73
2.95
%
18.56
228
1099
131
476
3.66
29.85
1.6
1.3
2.40
2.65
g/l
1.00
116
271
105
332
3.98
29.30
3.2
1.8
—
—
—
0
0
103
336
3.83
27.32
3.1
1.7
—
—
—
0
0
142
583
3.28
26.14
16.7
1.9
—
—
—
0
0
223
1217
2.99
24.37
24.0
5.2
46.02
57.97
%
20.29
216
1124
30
9
36.00
23.71
6.7
2.9
—
—
—
0
0
29
8
39.04
23.34
8.6
1.1
—
—
—
0
0
29
8
39.04
23.34
8.6
1.1
—
—
—
0
0
29
8
39.04
23.34
8.6
1.1
—
—
—
0
0
211
1137
2.91
23.28
17.0
2.2
—
—
—
0
0
34
18
20.59
23.04
1.3
1.7
—
—
—
0
0
30
14
23.13
21.16
8.5
1.1
—
—
—
0
0
30
14
23.13
21.16
8.5
1.1
—
—
—
0
0
241
1444
2.80
20.90
57.6
6.0
3.17
4.34
e9/l
1.60
229
1258
26
32
8.64
19.87
5.5
1.1
—
—
—
0
0
25
8
33.29
19.51
1.5
1.1
—
—
—
0
0
26
33
8.38
19.38
5.5
1.1
—
—
—
0
0
26
33
8.38
19.38
5.5
1.1
—
—
—
0
0
26
33
8.38
19.38
5.5
1.1
—
—
—
0
0
26
33
8.38
19.38
5.5
1.1
—
—
—
0
0
26
33
8.38
19.38
5.5
1.1
—
—
—
0
0
225
1336
2.66
19.30
27.5
5.4
0.12
0.20
e9/l
14.31
203
1177
25
9
29.58
18.97
2.9
1.0
—
—
—
0
0
25
9
29.58
18.97
2.9
1.0
—
—
—
0
0
23
6
40.64
18.77
3.1
1.0
—
—
—
0
0
23
6
40.64
18.77
3.1
1.0
—
—
—
0
0
32
55
6.26
18.21
4.8
1.2
—
—
—
0
0
28
17
17.66
18.15
1.5
1.8
—
—
—
0
0
28
17
17.66
18.15
1.5
1.8
—
—
—
0
0
25
12
22.18
17.53
1.8
1.5
36.92
49.94
%
—
12
7
224
1368
2.54
17.51
24.0
5.5
1.21
1.21
mmol/l
0.38
196
1172
207
1240
2.46
16.57
20.0
5.2
1.20
1.21
mmol/l
1.45
199
1094
196
1152
2.44
16.28
20.3
3.5
32.23
35.50
g/l
11.29
191
1056
151
802
2.46
15.55
6.6
2.6
30.69
33.33
u/l
0.56
146
760
21
10
22.12
14.82
1.1
1.0
—
—
—
0
0
26
23
12.04
14.51
1.3
1.1
—
—
—
0
0
27
26
11.08
14.47
6.3
1.3
33.04
34.15
pg
0.45
27
26
44
123
3.91
14.13
8.5
1.5
—
—
—
0
0
22
14
16.58
14.10
1.2
1.1
—
—
—
0
0
32
70
4.90
14.04
1.1
1.2
34.16
49.97
mg/l
2.13
27
62
26
49
5.62
13.43
2.2
1.3
—
—
—
0
0
30
68
4.70
12.61
1.1
1.2
—
1.51
—
0
5
39
111
3.80
12.19
3.5
1.4
—
—
—
0
0
25
50
5.28
12.11
1.6
1.5
—
—
—
0
0
15
5
31.12
11.73
1.1
1.0
—
—
—
0
0
84
384
2.52
11.54
1.5
2.3
2.03
2.28
g/l
4.43
79
351
56
210
2.95
11.29
1.9
2.1
0.21
0.20
g/l
0.30
50
187
50
176
3.12
11.24
3.7
1.6
—
—
—
0
0
79
361
2.50
10.82
1.6
2.4
37.57
23.24
%
4.95
61
313
142
861
2.03
9.61
5.5
2.1
2.30
2.35
mmol/l
3.75
130
700
14
8
18.10
9.47
2.6
1.3
—
—
—
0
0
20
41
5.09
9.42
8.3
3.0
43.30
60.37
%
3.19
20
41
173
1137
1.95
9.20
4.1
2.7
878.68
125.33
ug/l
4.99
164
1030
24
59
4.27
9.12
1.2
1.2
—
—
—
0
0
71
335
2.37
8.98
15.1
5.4
104.85
104.22
mmol/l
0.66
71
335
23
56
4.31
8.84
2.5
1.3
3.77
4.10
mmol/l
0.75
23
50
46
179
2.78
8.62
1.7
1.4
—
—
—
0
0
23
61
3.95
7.92
1.6
1.2
—
—
—
0
0
23
61
3.95
7.92
1.6
1.2
—
—
—
0
0
192
1374
1.80
7.30
15.7
17.7
1.27
1.40
inr
1.00
53
374
15
19
8.17
7.17
2.9
1.3
—
—
—
0
0
19
47
4.20
7.16
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
92
3.20
7.04
3.4
3.2
0.32
0.40
u/ml
0.40
13
52
148
988
1.81
7.03
5.2
3.1
—
—
—
0
0
31
110
2.98
6.86
1.3
1.2
—
—
—
0
0
119
751
1.85
6.74
2.1
2.2
2.62
3.04
mg/l
1.36
97
625
11
9
12.54
6.62
2.7
1.2
—
—
—
0
0
11
9
12.54
6.62
2.7
1.2
—
—
—
0
0
13
15
8.93
6.60
4.4
1.3
—
—
—
0
0
222
2711
0.57
6.57
4.7
5.2
2.60
2.64
mmol/l
0.27
206
2453
11
10
11.28
6.33
5.7
1.5
208.36
194.10
u/l
—
11
10
12
13
9.49
6.33
2.6
1.2
—
—
—
0
0
43
194
2.37
5.96
6.5
4.4
1.13
1.91
mmol/l
1.01
37
137
96
587
1.85
5.93
4.5
4.1
88.29
335.83
ng/l
1.41
82
489
21
66
3.31
5.68
1.1
1.3
—
—
—
0
0
22
73
3.14
5.47
1.4
1.2
0.00
0.00
g/l
-0.00
22
68
17
48
3.66
5.38
3.2
1.2
10.47
27.95
iu/l
1.82
12
42
33
139
2.50
5.31
3.6
1.4
3.31
2.72
ug/l
0.31
28
101
263
3023
0.59
5.29
92.1
19.4
3.62
4.48
e12/l
46.54
257
2915
263
3022
0.59
5.26
92.2
19.4
156.39
244.07
e9/l
27.90
257
2922
263
3021
0.59
5.23
92.6
19.5
32.55
40.05
%
39.39
240
2774
5
0
+∞
5.22
12.4
0.0
—
—
—
0
0
5
0
+∞
5.22
7.6
0.0
—
—
—
0
0
210
2547
0.61
5.21
5.3
6.4
40.25
40.88
mmol/mol
0.46
195
2320
11
15
7.51
5.17
2.8
1.8
1217.91
631.47
u/ml
2.14
11
15
218
2618
0.61
5.15
4.4
4.6
1.27
1.45
mmol/l
7.79
199
2370
22
76
3.01
5.12
1.4
1.2
0.00
0.00
g/l
-0.00
22
69
75
444
1.86
5.08
4.9
2.8
3.05
2.97
e6/l
0.02
42
246
22
81
2.82
4.60
1.4
1.2
0.00
0.07
g/l
0.49
22
74
7
5
14.22
4.59
2.1
7.2
—
—
—
0
0
9
11
8.35
4.58
1.8
1.3
—
—
—
0
0
53
291
1.95
4.49
5.0
3.6
1.92
2.10
mmol/l
0.11
44
236
119
835
1.62
4.32
4.3
2.2
49.03
62.95
u/l
1.57
108
770
226
2645
0.64
4.14
5.0
4.6
4.31
4.51
mmol/l
1.82
212
2403
228
2661
0.65
4.09
6.4
4.8
6.07
6.08
mmol/l
0.01
211
2377
56
326
1.84
3.98
8.8
6.7
1.48
1.57
mmol/l
0.06
44
255
97
660
1.63
3.95
1.8
1.8
1314.32
1137.05
nmol/l
0.93
86
495
8
12
6.78
3.69
1.4
1.2
—
—
—
0
0
7
9
7.90
3.57
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
13
6.26
3.52
1.4
1.2
—
—
—
0
0
217
1797
1.48
3.47
6.6
4.5
280.62
3923.87
e6/l
—
8
31
73
479
1.65
3.41
4.9
2.7
1.53
1.23
e6/l
0.15
42
280
9
18
5.09
3.39
1.1
1.0
—
—
—
0
0
107
771
1.54
3.37
5.2
2.9
0.36
0.44
e6/l
0.24
84
586
257
2882
0.67
3.21
45.8
8.8
28.55
24.96
u/l
3.05
250
2735
161
1272
1.46
3.20
2.3
2.1
87.29
93.17
pmol/l
0.95
118
632
7
11
6.46
3.20
1.1
1.0
—
—
—
0
0
218
2517
0.69
3.15
51.5
12.1
78.82
76.71
ml/min/173m2
0.66
186
2023
219
2518
0.70
3.00
5.4
4.6
1.95
1.95
mu/l
0.03
203
2251
10
26
3.92
3.00
4.6
4.6
—
—
—
0
0
5
5
10.11
2.98
1.0
1.4
—
—
—
0
0
6
9
6.75
2.87
1.3
1.1
—
—
—
0
0
29
154
1.96
2.74
2.0
2.5
1.12
0.24
e6/l
0.52
29
149
5
7
7.22
2.55
1.6
5.6
110.60
79.71
%
—
5
7
6
11
5.52
2.55
1.8
2.3
25.83
26.27
umol/l
—
6
11
223
2525
0.72
2.51
5.6
4.2
1.56
1.27
mmol/l
5.84
208
2267
10
32
3.18
2.45
1.1
1.8
—
—
—
0
0
259
2857
0.71
2.43
61.2
16.4
138.78
139.69
mmol/l
6.78
254
2754
6
13
4.67
2.28
1.5
1.2
13.62
12.00
ug/l
—
6
13
9
29
3.15
2.24
1.2
1.2
—
—
—
0
0
5
9
5.61
2.22
1.2
1.1
—
—
—
0
0
5
9
5.61
2.22
1.2
1.1
—
—
—
0
0
120
952
1.38
2.18
3.5
3.3
1289.96
1893.07
ng/l
1.57
115
809
38
238
1.66
2.14
2.4
2.0
28.97
31.75
u/l
0.33
33
195
5
10
5.05
2.07
1.0
1.5
—
—
—
0
0
18
90
2.05
2.04
1.3
1.2
—
—
—
0
0
16
77
2.12
1.99
1.6
1.4
—
—
—
0
0
18
91
2.03
1.98
1.3
1.2
—
—
—
0
0
9
200
0.44
1.89
2.2
2.0
—
—
—
0
0
10
220
0.44
1.85
2.1
2.2
—
—
—
0
0
37
543
0.65
1.75
1.3
1.2
0.92
1.58
u/ml
—
9
146
12
56
2.18
1.62
1.0
1.1
—
—
—
0
0
180
2033
0.78
1.58
4.8
3.7
14.73
14.94
pmol/l
0.47
165
1817
74
936
0.74
1.53
2.9
3.9
4.61
8.68
mg/mmol
1.64
47
599
11
51
2.19
1.52
1.2
1.4
—
—
—
0
0
139
1180
1.28
1.50
3.7
3.9
35.31
68.40
ng/l
0.60
111
853
14
73
1.95
1.45
7.8
5.6
1.24
1.58
mg/l
1.91
14
65
22
136
1.66
1.36
1.4
1.3
—
—
—
0
0
13
68
1.94
1.35
1.8
1.9
110.92
131.23
g/l
1.79
13
47
6
24
2.52
1.31
4.5
1.8
4.60
156.98
u/ml
—
6
24
131
1129
1.24
1.21
2.6
2.3
73.71
76.09
nmol/l
0.45
118
975
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
81
668
1.27
1.09
1.6
1.8
443.77
428.99
pmol/l
0.16
70
533
89
1050
0.80
1.05
4.3
3.9
2.18
2.09
ug/l
0.10
80
916
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
68
822
0.79
0.99
4.1
3.8
19.70
24.65
%
1.53
33
386
64
520
1.28
0.97
2.6
2.1
2.43
2.44
mmol/l
0.08
56
433
12
69
1.76
0.97
1.7
1.6
15346.00
15208.47
e6/l
—
7
47
7
36
1.96
0.97
1.1
1.4
—
—
—
0
0
222
2051
1.20
0.96
5.7
4.1
25.38
12.09
mm/h
11.73
209
1849
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
10
171
0.57
0.94
2.7
1.7
—
—
—
0
0
6
30
2.02
0.87
2.0
1.1
—
—
—
0
0
6
30
2.02
0.87
1.0
1.1
—
—
—
0
0
6
30
2.02
0.87
1.0
1.1
—
—
—
0
0
7
121
0.57
0.79
1.1
1.0
—
—
—
0
0
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
260
2731
0.85
0.75
73.3
13.3
35.57
24.33
mg/l
4.88
248
2120
9
54
1.68
0.75
1.3
1.3
—
—
—
0
0
181
1671
1.16
0.72
4.7
3.0
68.54
46.84
u/l
2.16
171
1526
7
40
1.76
0.71
1.1
1.6
—
—
—
0
0
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
44
363
1.24
0.62
3.0
5.0
27.03
32.17
%
2.62
36
229
47
560
0.82
0.62
2.9
2.7
0.84
0.79
ug/l
0.14
27
380
47
393
1.22
0.59
1.4
1.4
—
—
—
0
0
103
927
1.15
0.57
3.1
2.2
129.18
305.37
u/l
1.25
96
858
9
60
1.51
0.54
2.9
1.7
11.22
16.73
u/ml
—
9
44
39
456
0.84
0.44
1.2
1.3
14.88
33.49
iu/ml
2.79
13
150
141
1320
1.11
0.41
3.8
3.9
0.00
0.00
estimate
-0.00
29
231
31
261
1.20
0.39
7.1
3.2
—
—
—
0
0
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
19
152
1.26
0.37
1.1
1.2
74.60
120.17
iu/ml
—
5
63
5
79
0.63
0.36
1.2
1.8
—
—
—
0
0
18
220
0.81
0.33
4.3
2.2
59.71
62.14
ml/min/173m2
—
7
88
141
1337
1.09
0.31
3.9
3.9
0.00
0.00
estimate
-0.00
26
210
19
159
1.21
0.27
4.1
3.4
24.67
25.09
mmol/l
0.17
19
154
38
425
0.88
0.27
1.2
1.3
1.33
11.49
u/ml
3.07
11
165
76
712
1.08
0.23
3.6
4.0
0.00
0.00
estimate
-0.00
26
206
137
1314
1.07
0.22
5.6
5.3
0.00
0.00
estimate
-0.00
26
209
0
11
0.00
0.21
0.0
1.0
—
9.25
—
0
11
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
15.96
—
0
10
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
29
259
1.13
0.21
1.5
1.7
1.65
1.52
%
0.35
24
225
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
6
52
1.16
0.19
1.5
1.4
—
—
—
0
0
8
71
1.13
0.16
1.5
1.5
—
—
—
0
0
107
1030
1.05
0.15
3.8
4.0
—
—
—
0
0
9
110
0.81
0.13
2.1
2.0
—
—
—
0
0
37
391
0.94
0.10
14.4
7.5
—
—
—
0
0
5
65
0.77
0.08
1.2
1.2
—
—
—
0
0
16
148
1.08
0.06
6.9
2.5
1.39
1.17
%
0.74
16
148
151
1525
0.98
0.03
4.0
2.7
—
—
—
0
0
15
142
1.06
0.02
2.8
2.5
0.73
0.65
%
0.48
15
142
29
286
1.02
0.00
1.6
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
9
98
0.92
-0.00
1.0
2.0
—
—
—
0
0
9
90
1.00
-0.00
1.7
1.9
—
—
—
0
0
7
76
0.92
-0.00
1.3
1.2
—
3.45
—
0
11
5
49
1.02
-0.00
4.0
2.3
107.40
104.88
mmol/l
—
5
49
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
78
0.90
-0.00
1.3
1.2
—
9.22
—
0
13
5
56
0.89
-0.00
1.8
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HLP_C3_AML – Acute myeloid leukaemia, helper endpoint
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).